Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,198 | 544 | 82.3% |
| Travel and Lodging | $1,657 | 8 | 13.4% |
| Education | $510.73 | 27 | 4.1% |
| Gift | $25.87 | 11 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,420 | 122 | $0 (2024) |
| COLOPLAST CORP | $1,269 | 20 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,169 | 14 | $0 (2021) |
| PFIZER INC. | $634.15 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $591.02 | 27 | $0 (2024) |
| Allergan, Inc. | $550.06 | 39 | $0 (2020) |
| Minerva Surgical, Inc | $433.71 | 4 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $424.93 | 17 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $421.10 | 25 | $0 (2021) |
| Daiichi Sankyo Inc. | $387.43 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,448 | 103 | ABBVIE INC. ($270.80) |
| 2023 | $1,383 | 57 | ABBVIE INC. ($289.54) |
| 2022 | $1,225 | 72 | ABBVIE INC. ($342.72) |
| 2021 | $1,819 | 94 | AbbVie Inc. ($753.82) |
| 2020 | $815.97 | 59 | Allergan, Inc. ($180.26) |
| 2019 | $2,275 | 78 | Coloplast Corp ($1,118) |
| 2018 | $2,480 | 67 | Bayer HealthCare Pharmaceuticals Inc. ($1,136) |
| 2017 | $946.09 | 60 | PFIZER INC. ($220.10) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Obesity | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 12/09/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 12/02/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Obesity | ||||||
| 11/21/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $108.10 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $9.83 | General |
| 10/29/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: ETONOGESTREL | ||||||
| 10/28/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/28/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/14/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Women's Health | ||||||
| 10/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.76 | General |
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Biological | ||||||
| 10/07/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 111 | 141 | $22,304 | $7,796 |
| 2022 | 5 | 104 | 123 | $13,022 | $5,938 |
| 2021 | 6 | 146 | 169 | $15,304 | $8,145 |
| 2020 | 5 | 101 | 111 | $10,052 | $3,890 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 45 | $9,407 | $3,507 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 32 | $4,145 | $1,799 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,592 | $1,213 | 33.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 12 | 14 | $4,561 | $1,167 | 25.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 18 | $267.12 | $61.38 | 23.0% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 21 | 21 | $331.05 | $48.72 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 33 | $6,898 | $2,757 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 37 | $4,793 | $2,305 | 48.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 13 | 13 | $595.22 | $463.79 | 77.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 12 | 12 | $454.62 | $347.36 | 76.4% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 28 | 28 | $281.36 | $65.54 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 41 | $5,098 | $2,790 | 54.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 24 | $5,017 | $2,151 | 42.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 28 | 28 | $1,633 | $1,138 | 69.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 28 | 28 | $1,491 | $1,036 | 69.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,695 | $941.93 | 55.6% |
| 85018 | Blood count, hemoglobin | Office | 2021 | 36 | 37 | $371.11 | $87.69 | 23.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 18 | $3,903 | $1,141 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 22 | $2,726 | $1,049 | 38.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 21 | 21 | $2,186 | $845.67 | 38.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 21 | 21 | $1,091 | $786.78 | 72.1% |
| 85018 | Hemoglobin measurement | Office | 2020 | 29 | 29 | $145.87 | $68.23 | 46.8% |
About Dr. Laura Lebel, MD
Dr. Laura Lebel, MD is a Obstetrics & Gynecology healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972694016.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Lebel, MD has received a total of $12,391 in payments from pharmaceutical and medical device companies, with $1,448 received in 2024. These payments were reported across 590 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,198).
As a Medicare-enrolled provider, Lebel has provided services to 462 Medicare beneficiaries, totaling 544 services with total Medicare billing of $25,770. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Greenville, SC
- Active Since 09/27/2006
- Last Updated 10/31/2014
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1972694016
Products in Payments
- ALTIS (Device) $1,146
- Essure (Device) $1,136
- VRAYLAR (Drug) $884.05
- MYFEMBREE (Drug) $648.08
- INJECTAFER (Drug) $387.43
- CONTRAVE (Drug) $354.78
- UBRELVY (Drug) $349.04
- Orilissa (Drug) $332.79
- LO LOESTRIN FE (Drug) $323.33
- INTRAROSA (Drug) $316.31
- PREMARIN (Drug) $259.05
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $248.44
- Lupron (Drug) $246.79
- QULIPTA (Drug) $235.91
- PREMARIN ORALS (Drug) $220.93
- ZURZUVAE (Drug) $220.44
- MYRBETRIQ (Drug) $218.91
- Osphena (Drug) $217.31
- NURTEC ODT (Drug) $213.06
- ANNOVERA (Drug) $204.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Greenville
William Coleman, M.d, M.D
Obstetrics & Gynecology — Payments: $273,846
Paul Miller, M.d, M.D
Obstetrics & Gynecology — Payments: $225,031
Charis Chambers, M.d, M.D
Obstetrics & Gynecology — Payments: $24,129
Harris Wexler, D.o, D.O
Obstetrics & Gynecology — Payments: $11,764
Dr. Rebecca Rinko, Do, DO
Obstetrics & Gynecology — Payments: $10,512
William Brown, Md, MD
Obstetrics & Gynecology — Payments: $9,126